Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRX167700 in Knee Osteoarthritis
2013-001970-33Phase 2Completed
- Sponsor
- Proximagen
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of PRX167700 in knee osteoarthritis (OA) (2 arms), sponsored by Proximagen. Primary endpoint: Pain intensity at rest and after walking 100 m. Started Jun 2013; status: completed.
02
Drugs
PRX167700
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2013-001970-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001970-33.